Cellectar Biosciences, Inc. (CLRB)
Largest Insider Buys in Sector
CLRB Stock Price History Chart
CLRB Stock Performance
About Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.
Insider Activity of Cellectar Biosciences, Inc.
Over the last 12 months, insiders at Cellectar Biosciences, Inc. have bought $0 and sold $0 worth of Cellectar Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Cellectar Biosciences, Inc. have bought $139,443 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $26,000 was made by Swirsky Douglas J (director) on 2021‑09‑14.
List of Insider Buy and Sell Transactions, Cellectar Biosciences, Inc.
| 2021-09-14 | director | 25,000 0.0418% | $1.04 | $26,000 | -43.80% | |||
| 2021-09-03 | director | 19,417 0.0328% | $1.04 | $20,244 | -42.72% | |||
| 2021-03-04 | President and CEO | 5,100 0.0103% | $1.70 | $8,659 | -43.68% | |||
| 2020-12-28 | Chief Business Officer | 29,630 0.0975% | $1.35 | $40,001 | -41.79% | |||
| 2020-12-28 | President and CEO | 37,037 0.1219% | $1.35 | $50,000 | -41.79% | |||
| 2020-12-28 | Chief Financial Officer | 7,407 0.0244% | $1.35 | $9,999 | -41.79% | |||
| 2020-06-05 | Chief Business Officer | 65,218 0.4749% | $1.15 | $74,675 | +26.32% | |||
| 2020-06-05 | President and CEO | 21,740 0.1583% | $1.15 | $24,892 | +26.32% | |||
| 2020-06-05 | Chief Financial Officer | 4,348 0.0317% | $1.15 | $4,978 | +26.32% | |||
| 2020-06-04 | director | 18,000 0.1236% | $1.08 | $19,438 | +25.88% | |||
| 2019-02-28 | Chief Business Officer | 100 0.0021% | $2.00 | $200 | +6.90% | |||
| 2018-11-30 | President and CEO | 1,000 0.0345% | $2.28 | $2,282 | -4.93% | |||
| 2018-11-29 | Sale | director | 992 0.0329% | $2.21 | $2,192 | -5.78% | ||
| 2018-08-16 | Chief Business Officer | 500 0.0149% | $2.71 | $1,355 | -22.38% | |||
| 2018-03-13 | Sale | Chief Business Officer | 13,000 0.0783% | $1.18 | $15,397 | -76.50% | ||
| 2018-03-12 | Sale | President and CEO | 34,000 0.2018% | $1.20 | $40,705 | -77.08% | ||
| 2017-11-14 | Sale | director | 5,214 0.0315% | $1.49 | $7,791 | -27.89% | ||
| 2016-11-29 | director | 333,333 2.668% | $1.49 | $496,666 | +6.45% | |||
| 2016-10-31 | Sale | 21,000 0.1919% | $2.03 | $42,609 | -9.19% | |||
| 2016-04-21 | 7,516 0.1746% | $1.90 | $14,280 | +21.69% |
Insider Historical Profitability
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10 percent owner | 1142368 2.768% | $0.28 | 4 | 0 | |
| NEIS JOHN | director | 626103 1.5171% | $0.28 | 3 | 1 | +9.32% |
| Hertzberg Richard | 280000 0.6785% | $0.28 | 12 | 1 | <0.0001% | |
| BERNS PAUL L | director | 117371 0.2844% | $0.28 | 1 | 0 | +12.2% |
| Longcor Jarrod | Chief Business Officer | 102148 0.2475% | $0.28 | 4 | 1 | <0.0001% |
| CARUSO JAMES V | President and CEO | 86401 0.2094% | $0.28 | 9 | 1 | <0.0001% |
| Swirsky Douglas J | director | 25000 0.0606% | $0.28 | 1 | 0 | <0.0001% |
| DRISCOLL FREDERICK W | director | 19417 0.047% | $0.28 | 1 | 0 | <0.0001% |
| HILL STEPHEN A | director | 18000 0.0436% | $0.28 | 3 | 1 | +19.04% |
| Pedder Simon | President and CEO | 13300 0.0322% | $0.28 | 1 | 0 | |
| Elefant Dov | Chief Financial Officer | 11755 0.0285% | $0.28 | 2 | 0 | <0.0001% |
| AWM Investment Company, Inc. | 10 percent owner | 0 0% | $0.28 | 0 | 28 |
Institutional Investor Ownership
| Aigh Capital Management Llc | $11.16M | 7.82 | 2.8M | +46.45% | +$3.54M | 6.38 | |
| Nantahala Capital Management Llc | $7.46M | 5.23 | 1.87M | +38.7% | +$2.08M | 0.35 | |
| The Vanguard Group | $4.74M | 3.32 | 1.19M | +146.66% | +$2.82M | <0.0001 | |
| Barclays | $1.35M | 0.94 | 338,198 | New | +$1.35M | <0.01 | |
| Geode Capital Management | $1.26M | 0.88 | 316,084 | +358.96% | +$983,984.21 | <0.0001 | |
| Hudson Bay Capital Management LP | $597,000.00 | 0.42 | 150,000 | New | +$597,000.00 | <0.01 | |
| ACUTA CAPITAL PARTNERS LLC | $571,130.00 | 0.4 | 143,500 | -69.95% | -$1.33M | 0.37 | |
| BlackRock | $566,680.00 | 0.4 | 142,382 | +149.61% | +$339,652.98 | <0.0001 | |
| Lighthouse Investment Partners, LLC | $552,269.00 | 0.39 | 138,761 | New | +$552,269.00 | 0.03 | |
| Citadel Advisors LLC | $468,402.00 | 0.33 | 117,689 | +70.55% | +$193,754.27 | <0.0001 | |
| State Street | $419,548.00 | 0.29 | 105,414 | +570.83% | +$357,006.24 | <0.0001 | |
| Renaissance Technologies | $392,000.00 | 0.28 | 98,500 | New | +$392,000.00 | <0.01 | |
| Jane Street Capital | $236,492.00 | 0.17 | 59,420 | New | +$236,492.00 | <0.0001 | |
| Northern Trust | $208,357.00 | 0.15 | 52,351 | +312.67% | +$157,866.71 | <0.0001 | |
| Newedge Advisors Llc | $177,679.00 | 0.13 | 44,643 | +112.45% | +$94,047.33 | <0.01 | |
| Raymond James Associates | $143,380.00 | 0.1 | 36,025 | New | +$143,380.00 | <0.0001 | |
| Raymond James Financial Services Advisors Inc | $119,400.00 | 0.08 | 30,000 | New | +$119,400.00 | <0.0001 | |
| Morgan Stanley | $84,579.00 | 0.06 | 21,251 | +41.15% | +$24,656.11 | <0.0001 | |
| Integrated Wealth Concepts Llc | $79,600.00 | 0.06 | 20,000 | New | +$79,600.00 | <0.01 | |
| Two Sigma | $80,519.00 | 0.06 | 20,231 | New | +$80,519.00 | <0.0001 | |
| Bank of America | $77,188.00 | 0.05 | 19,394 | +121,112.5% | +$77,124.32 | <0.0001 | |
| OMERS | $71,640.00 | 0.05 | 18,000 | New | +$71,640.00 | <0.01 | |
| Squarepoint Ops LLC | $71,469.00 | 0.05 | 17,957 | New | +$71,469.00 | <0.0001 | |
| Susquehanna International Group | $71,011.00 | 0.05 | 17,842 | New | +$71,011.00 | <0.0001 | |
| Commerce Bank | $63,680.00 | 0.05 | 16,000 | +33.33% | +$15,920.00 | <0.0001 | |
| Coastal Bridge Advisors Llc | $63,680.00 | 0.05 | 16,000 | -30.43% | -$27,860.00 | 0.01 | |
| Two Sigma Advisers LP | $53,332.00 | 0.04 | 13,400 | New | +$53,332.00 | <0.0001 | |
| Xtx Topco Ltd | $47,326.00 | 0.03 | 11,891 | New | +$47,326.00 | <0.01 | |
| Group One Trading | $31,840.00 | 0.02 | 8,000 | New | +$31,840.00 | <0.0001 | |
| UBS | $23,681.00 | 0.02 | 5,950 | +395.83% | +$18,905.00 | <0.0001 | |
| Tower Research Capital | $21,584.00 | 0.02 | 5,423 | +47.12% | +$6,913.41 | <0.0001 | |
| Belvedere Trading LLC | $15,036.00 | 0.01 | 3,778 | New | +$15,036.00 | <0.01 | |
| Simplex Trading Llc | $14,000.00 | 0.01 | 3,678 | New | +$14,000.00 | <0.0001 | |
| Royal Bank of Canada | $10,000.00 | 0.01 | 2,500 | New | +$10,000.00 | <0.0001 | |
| Benefit Financial Services Group (BFSG) | $3,980.00 | <0.01 | 1,000 | New | +$3,980.00 | <0.01 | |
| U.S. Bancorp | $1,134.00 | <0.01 | 285 | 0% | +$0 | <0.0001 | |
| Ica Group Wealth Management Llc | $1,393.00 | <0.01 | 350 | New | +$1,393.00 | <0.0001 | |
| Wells Fargo | $816.00 | <0.01 | 205 | +241.67% | +$577.17 | <0.0001 | |
| PNC Financial Services | $1,194.00 | <0.01 | 300 | New | +$1,194.00 | <0.0001 | |
| Advisor Group Holdings Inc | $2,073.00 | <0.01 | 521 | 0% | +$0 | <0.0001 | |
| Harbour Investments Inc | $159.00 | <0.01 | 40 | 0% | +$0 | <0.0001 | |
| AllSquare Wealth Management, LLC | $72.00 | <0.01 | 18 | 0% | +$0 | <0.0001 |